From: Incremental cost-utility of sevelamer relative to calcium carbonate for treatment of hyperphosphatemia among pre-dialysis chronic kidney disease patients
Age
Percentage
0
20
1.2
30
3.5
40
8.4
50
21
60
24.9
70
80
15.7
